Patents by Inventor Benjamin RIBBA

Benjamin RIBBA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods relating to dosage regimen design
    Patent number: 12094586
    Abstract: The present invention provides materials and methods for determining optimal dosage regimens for therapeutic agents. In particular, the invention relates to dosage regimens for therapeutic agents capable of targeting IL-2 receptor, preferably interleukin 2 (IL2)-based therapeutic agents. The methods of the invention allow general dosage regimens to be determined for new IL-2R targeted therapeutic agents but also specifically tailored dosage regimens to be achieved for individuals being treated with IL-2R targeted therapeutic agents.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: September 17, 2024
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Hans Peter Grimm, Benjamin Ribba, Volker Teichgräaeber
  • MATERIALS AND METHODS RELATING TO DOSAGE REGIMEN DESIGN
    Publication number: 20190361018
    Abstract: The present invention provides materials and methods for determining optimal dosage regimens for therapeutic agents. In particular, the invention relates to dosage regimens for therapeutic agents capable of targeting IL-2 receptor, preferably interleukin 2 (IL2)-based therapeutic agents. The methods of the invention allow general dosage regimens to be determined for new IL-2R targeted therapeutic agents but also specifically tailored dosage regimens to be achieved for individuals being treated with IL-2R targeted therapeutic agents.
    Type: Application
    Filed: November 20, 2018
    Publication date: November 28, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Hans Peter GRIMM, Benjamin RIBBA, Volker TEICHGRAEBER